Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
Head and neck cancer (HNC) ranks the fourth leading malignancy and cancer death in male population in Taiwan. Despite recent therapeutic advances, the prognosis for HNC patients is still dismal. New strategies are urgently needed to improve the chemosensitization to conventional chemotherapeutic dru...
Main Authors: | Chuan-Hang Yu, Cheng-Chia Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3901774?pdf=render |
Similar Items
-
miR-145 mediates the anti-cancer stemness effect of photodynamic therapy with 5-aminolevulinic acid (ALA) in oral cancer cells
by: Chih-Yuan Fang, et al.
Published: (2018-08-01) -
Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
by: Jakub Golab, et al.
Published: (2011-05-01) -
Cancer stem cell populations are resistant to 5-aminolevulinic acid-photodynamic therapy (5-ALA-PDT)
by: Chantel P. J. Rice, et al.
Published: (2025-02-01) -
5-Aminolevulinic acid-mediated photodynamic therapy for oral cancers and precancers
by: Hsin-Ming Chen, et al.
Published: (2012-12-01) -
Enhancing oral cancer treatment via photodynamic therapy: Gold nanoparticle-based delivery system for 5-aminolevulinic acid (5-ALA)
by: Romesa Soomro, et al.
Published: (2024-09-01)